May 5, 2014 | Israeli company IceCure Medical, which uses an extreme-cold-based minimally-invasive procedure for removing tumors, has announced that is beginning clinical trials for treatment of malignant breast cancer tumors. In the past, the company has reported success in treating benign breast tumors and initial success in treating malignant lung cancer tumors.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments